Condensed Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stocks [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2024	$ 62	$ 349,738,841	$ (27)	$ (334,232,661)	$ 15,506,215
Beginning balance, shares at Jun. 30, 2024	621,640		(2,633)
Stock - based compensation - stock options		118,898			118,898
Stock-based compensation - restricted stock units		301,491			301,491
Issuance of common stock from vesting of restricted stock units
Issuance of common stock from vesting of restricted stock units, shares	341
Stock-based compensation - issuance of common stock for services rendered		33,450			33,450
Stock-based compensation - issuance of common stock for services rendered, shares	1,500
Proceeds from issuance of common stock, net of costs of $1,543,038	$ 16	2,259,047			2,259,063
Proceeds from issuance of common stock, net of costs of $747,408, shares	162,794
Issuance of additional shares for fractional shares effected by the reverse split	$ 1	(1)
Issuance of additional shares for fractional shares effected by the reverse split, shares	12,024
Deemed dividend for ratchet adjustment to warrants		325,041		(325,041)
Net Loss				(4,152,032)	(4,152,032)
Ending balance, value at Sep. 30, 2024	$ 79	352,776,767	$ (27)	(338,709,734)	14,067,085
Ending balance, shares at Sep. 30, 2024	798,299		(2,633)
Stock - based compensation - stock options		385,328			385,328
Stock-based compensation - restricted stock units		265,804			265,804
Issuance of common stock from vesting of restricted stock units
Issuance of common stock from vesting of restricted stock units, shares	381
Exercise of warrants	$ 22	2,901,319			2,901,341
Exercise of warrants, shares	223,130
Cashless exercise of warrants
Cashless exercise of warrants, shares	422
Proceeds from issuance of common stock, net of costs of $1,543,038	$ 83	13,415,467			13,415,550
Proceeds from issuance of common stock, net of costs of $747,408, shares	825,600
Deemed dividend for ratchet adjustment to warrants		44,424		(44,424)
Net Loss				(7,112,529)	(7,112,529)
Ending balance, value at Dec. 31, 2024	$ 184	369,789,109	$ (27)	(345,866,687)	23,922,579
Ending balance, shares at Dec. 31, 2024	1,847,832		(2,633)
Beginning balance, value at Jun. 30, 2025	$ 192	371,156,068	$ (29)	(352,144,246)	19,011,985
Beginning balance, shares at Jun. 30, 2025	1,917,061		(2,837)
Stock - based compensation - stock options		268,388			268,388
Stock-based compensation - restricted stock units and restricted shares		270,559			270,559
Issuance of common stock from vesting of restricted stock units
Issuance of common stock from vesting of restricted stock units, shares	3,255
Proceeds from issuance of common stock, net of costs of $1,543,038	$ 562	10,457,067			10,457,629
Proceeds from issuance of common stock, net of costs of $747,408, shares	5,620,000
Deemed dividend for ratchet adjustment to warrants		43,544		(43,544)
Net Loss				(5,087,557)	(5,087,557)
Ending balance, value at Sep. 30, 2025	$ 754	382,195,626	$ (29)	(357,275,347)	24,921,004
Ending balance, shares at Sep. 30, 2025	7,540,316		(2,837)
Stock - based compensation - stock options		197,336			197,336
Stock-based compensation - restricted stock units and restricted shares		216,169			216,169
Issuance of common stock from vesting of restricted stock units
Issuance of common stock from vesting of restricted stock units, shares	3,255
Net Loss				(6,069,475)	(6,069,475)
Ending balance, value at Dec. 31, 2025	$ 754	$ 382,609,131	$ (29)	$ (363,344,822)	$ 19,265,034
Ending balance, shares at Dec. 31, 2025	7,543,571		(2,837)

BIOVIE INC. 10-Q